DNAPrint Genomics, Inc.
DNAG · OTC
12/31/2006 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Revenue | $2,433 | $1,276 | $786 | $710 |
| % Growth | 90.7% | 62.4% | 10.7% | – |
| Cost of Goods Sold | $1,679 | $950 | $508 | $432 |
| Gross Profit | $754 | $325 | $278 | $277 |
| % Margin | 31% | 25.5% | 35.3% | 39.1% |
| R&D Expenses | $6,427 | $2,122 | $1,561 | $2,654 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,194 | $2,865 | $2,051 | $3,858 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$9,324 | -$6,669 | -$12,470 |
| Operating Expenses | -$8,113 | -$4,337 | -$3,057 | -$5,957 |
| Operating Income | -$8,867 | -$4,662 | $3,334 | $6,235 |
| % Margin | -364.5% | -365.5% | 424.4% | 878.6% |
| Other Income/Exp. Net | -$3,481 | -$4,662 | -$3,334 | -$6,235 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12,348 | -$8,716 | -$3,735 | -$7,790 |
| % Margin | -507.5% | -683.3% | -475.4% | -1,097.7% |
| EPS | -0.03 | -0.09 | -0.2 | -3.2 |
| % Growth | 66.7% | 55% | 93.8% | – |
| EPS Diluted | -0.03 | -0.09 | -0.2 | -3.2 |
| Weighted Avg Shares Out | 365,239 | 93,531 | 35,374 | 24,980 |
| Weighted Avg Shares Out Dil | 365,239 | 93,531 | 35,374 | 24,980 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,054 | $877 | $1,052 | $1,040 |
| EBITDA | -$8,930 | -$2,376 | -$2,283 | -$5,195 |
| % Margin | -367% | -186.2% | -290.5% | -732% |